Websites hosted on 54.163.225.126
Server (IP 54.163.225.126) has hosted these websites/domains at one point or another.
Number of websites/domains displayed: 20
Results found: 20
Websites discovered:
XARELTO® (rivaroxaban) | Prescription Blood Thinnerhttp://pageoverview.com/website-report/xarelto-us.com
Learn about prescription blood thinner XARELTO® including treatment information and cost. See Full Prescribing & Safety Info including Boxed Warnings.
- Expected expiration: March 16th in 2019
- Creation date: March 16th in 2009
- Renew date: March 12th in 2017
- Google Analytics: 70816641-13
Treatment & Support | PREZCOBIX® (darunavir 800 mg/cobicistat 150 mg)http://pageoverview.com/website-report/prezcobix.com
Learn how treatment with once-daily PREZCOBIX® (darunavir 800 mg/cobicistat 150 mg) may affect CD4+ cell count. See full Prescribing & Safety info.
- Expected expiration: June 10th in 2018
- Creation date: June 10th in 2014
- Renew date: May 14th in 2017
- Google Analytics: 2050685-23
AFib Stroke Risk & Treatment Info | Treat Your AFibhttp://pageoverview.com/website-report/myafibrisk.com
Get the facts about the connection between atrial fibrillation and stroke risk, and how treatment may help you reduce your stroke risk.
- Expected expiration: May 5th in 2018
- Creation date: May 5th in 2015
- Renew date: April 4th in 2017
- Google Analytics: 6230610-16
Janssen CarePath™ Patient Support Program | XARELTO® (rivaroxaban)http://pageoverview.com/website-report/xareltocarepath.com
Register for the Janssen CarePath Support Program to find valuable cost and savings information. See full Prescribing & Safety Info including Boxed Warnings.
- Expected expiration: March 17th in 2019
- Creation date: March 17th in 2011
- Renew date: March 13th in 2017
- Google Analytics: 70816641-13
INVEGA® SUSTENNA® (paliperidone palmitate)http://pageoverview.com/website-report/invegasustenna.com
- Expected expiration: March 19th in 2018
- Creation date: March 19th in 2008
- Renew date: March 14th in 2017
- Google Analytics: 614896-17
ZYTIGA® (abiraterone acetate)http://pageoverview.com/website-report/zytiga.com
- Expected expiration: August 12th in 2018
- Creation date: August 12th in 2010
- Renew date: July 12th in 2017
- Google Analytics: 1863405-99
Plaque Psoriasis & Psoriatic Arthritis | STELARA® (ustekinumab)http://pageoverview.com/website-report/stelarainfo.com
Learn about moderate to severe plaque psoriasis & active psoriatic arthritis treatment STELARA®. See Full Prescribing Info & Important Safety Information.
- Expected expiration: December 4th in 2017
- Creation date: December 4th in 2008
- Renew date: May 13th in 2017
- Google Analytics: 1863405-87
INVEGA SUSTENNA® (paliperidone palmitate) for HCPshttp://pageoverview.com/website-report/invegasustennahcp.com
Find information for health care professionals about INVEGA® SUSTENNA®. See full safety and Prescribing Information, including boxed WARNING.
- Expected expiration: July 11th in 2018
- Creation date: July 11th in 2014
- Renew date: June 9th in 2017
- Google Analytics: 70816641-3
AFib Stroke Risk & Treatment Info | Treat Your AFibhttp://pageoverview.com/website-report/myafibstory.com
Get the facts about the connection between atrial fibrillation and stroke risk, and how treatment may help you reduce your stroke risk.
- Expected expiration: July 10th in 2018
- Creation date: July 10th in 2014
- Renew date: June 9th in 2017
- Google Analytics: 6230610-16
ZYTIGA® (abiraterone acetate) | HCPhttp://pageoverview.com/website-report/zytigahcp.com
- Expected expiration: October 18th in 2017
- Creation date: October 18th in 2011
- Renew date: October 14th in 2016
- Google Analytics: 1863405-91
Moderate to severe plaque psoriasis treatment | TREMFYA™ (guselkumab)http://pageoverview.com/website-report/tremfya.com
Learn about TREMFYA™ (guselkumab), which is approved for adult patients with moderate to severe plaque psoriasis. See full Prescribing Info & Important Safety Info
- Expected expiration: February 19th in 2019
- Creation date: February 19th in 2016
- Renew date: October 9th in 2017
- Google Analytics: 70816641-32
Official Website for REMICADE® (infliximab)http://pageoverview.com/website-report/remicade.com
Learn about treatment with REMICADE® (infliximab) across all uses and see Important Safety Information and Medication Guide for discussion with your doctor.
- Expected expiration: June 23rd in 2017
- Creation date: June 24th in 1998
- Renew date: May 13th in 2017
- Google Analytics: 1863405-7
INVEGA TRINZA® (paliperidone palmitate) | Homepagehttp://pageoverview.com/website-report/invegatrinza.com
Learn about INVEGA TRINZA® including condition and treatment information. See full Prescribing and Important Safety Information including Boxed Warning.
- Expected expiration: October 17th in 2018
- Creation date: October 17th in 2014
- Renew date: September 16th in 2017
- Google Analytics: 614896-47
Treatment with INVOKANA® (canagliflozin)http://pageoverview.com/website-report/invokana.com
Learn about INVOKANA® (canagliflozin), an SGLT2 inhibitor that helps lower blood sugar in adults. See full prescribing and safety information.
- Expected expiration: August 15th in 2017
- Creation date: August 15th in 2012
- Renew date: August 11th in 2016
- Google Analytics: 1724827-37
INVOKANA® (canagliflozin) Treatment | HCPhttp://pageoverview.com/website-report/invokanahcp.com
Learn more about a once-daily treatment option that can help lower blood glucose in adults. See full Prescribing and safety info.
- Expected expiration: August 14th in 2017
- Creation date: August 14th in 2012
- Renew date: May 12th in 2017
- Google Analytics: 70816641-5
STELARA® (ustekinumab)http://pageoverview.com/website-report/stelarahcp.com
- Expected expiration: March 28th in 2018
- Creation date: March 28th in 2014
- Renew date: May 13th in 2017